Co
Compass Inc
New York NYFounded 20123,000 employees
Private CapbiotechPrivateOncology
Platform: RE Tech n/a
Market Cap
N/A
All Drugs
3
Clinical Trials
7
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Lisocagene | COM-6156 | Phase 1 | 1 | AuroraA | Crohn'sRB | ||
| Miricapivasertib | COM-9180 | Phase 3 | 4 | PRMT5 | CTCLMM | ||
| Suraderotide | COM-7897 | Phase 1 | 2 | TIGIT | SchizophreniaADHD |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (7)